Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference
02 févr. 2023 08h00 HE
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Life Sciences Announces Granting of New Hire Inducement Award
27 janv. 2023 16h30 HE
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development...
Synergy Life Science Releases Nebi, a Groundbreaking, Portable Nebulizer
25 janv. 2023 09h30 HE
|
Synergy Life Science
BUFORD, Ga. , Jan. 25, 2023 (GLOBE NEWSWIRE) -- Synergy Life Science, Inc. (“Synergy”), a company pioneering the development of novel ingredients and innovative products for the consumer health and...
Global Nicotine Gum Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts
17 janv. 2023 05h13 HE
|
Research and Markets
Dublin, Jan. 17, 2023 (GLOBE NEWSWIRE) -- The "Nicotine Gum Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Smoking Cessation and Nicotine De-Addiction Products Market Report 2022: Featuring British American Tobacco, Cipla, Dr. Reddy's Laboratories & More
12 janv. 2023 08h28 HE
|
Research and Markets
Dublin, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The "Smoking Cessation and Nicotine De-Addiction Products Market By Product, By Form, By Distribution Channel: Global Opportunity Analysis and Industry...
Achieve Life Sciences Announces Last Subject Dosed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
09 janv. 2023 08h00 HE
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation
21 déc. 2022 08h00 HE
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global...
Smoking Cessation and Nicotine De-Addiction Products Global Market to Grow by 15% Annually Through 2030
01 déc. 2022 07h33 HE
|
Research and Markets
Dublin, Dec. 01, 2022 (GLOBE NEWSWIRE) -- The "Smoking Cessation and Nicotine De-Addiction Products Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players,...
Achieve Life Sciences Announces Private Placement of $18.9 Million
15 nov. 2022 08h00 HE
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Reports Financial Results for Third Quarter 2022 and Provides Corporate Update
14 nov. 2022 16h05 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...